0001438133-24-000011.txt : 20240220
0001438133-24-000011.hdr.sgml : 20240220
20240220192631
ACCESSION NUMBER: 0001438133-24-000011
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240215
FILED AS OF DATE: 20240220
DATE AS OF CHANGE: 20240220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sheridan John F
CENTRAL INDEX KEY: 0001365369
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36189
FILM NUMBER: 24655824
MAIL ADDRESS:
STREET 1: C/O TANDEM DIABETES CARE, INC.
STREET 2: 11045 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC
CENTRAL INDEX KEY: 0001438133
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 204327508
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12400 HIGH BLUFF DRIVE
CITY: San Diego
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-366-6900
MAIL ADDRESS:
STREET 1: 12400 HIGH BLUFF DRIVE
CITY: San Diego
STATE: CA
ZIP: 92130
4
1
wk-form4_1708475167.xml
FORM 4
X0508
4
2024-02-15
0
0001438133
TANDEM DIABETES CARE INC
TNDM
0001365369
Sheridan John F
12400 HIGH BLUFF DRIVE
SAN DIEGO
CA
92130
1
1
0
0
PRESIDENT & CEO
0
Common Stock
2024-02-15
4
M
0
793
0
A
28368
D
Common Stock
2024-02-15
4
F
0
325
24.29
D
28043
D
Common Stock
2024-02-15
4
M
0
2236
0
A
30279
D
Common Stock
2024-02-15
4
F
0
917
24.29
D
29362
D
Restricted Stock Unit
2024-02-15
4
M
0
793
0
D
Common Stock
793
3962
D
Restricted Stock Unit
2024-02-15
4
M
0
2236
0
D
Common Stock
2236
11182
D
Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.
Awarded on May 25, 2022 pursuant to the 2013 Plan.
RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
/s/ Rachel Malina, Attorney-in-Fact for John F. Sheridan
2024-02-20